BAT Invests C$65.2 Million in Organigram to Fund Sanity Group Acquisition

Organigram Global Inc. has entered into a subscription agreement with British American Tobacco (BAT) for a C$65.2 million private placement investment. The capital injection is specifically designated to fund the previously announced acquisition of Sanity Group GmbH. The investment is being made through a wholly-owned subsidiary of BAT, further solidifying the strategic alliance between the two companies. This funding provides Organigram with the necessary financial resources to execute its international expansion and M&A strategy. Market analysts view this move as a significant endorsement of Organigram’s growth potential within the evolving cannabis sector. The partnership with a global giant like BAT is expected to enhance Organigram's market positioning and operational scale.